Johnson & Johnson Stock Forecast for 2022 - 2025 - 2030

Updated on 05/19/2022

Stock Rating
2 / 10
Price Target
$187.12
Consensus
Outperform
Upside
5.41%
Analysts
16
Stock Rating
2
Upside
5.41%
Analysts
16
Price Target
$187.12

Johnson & Johnson's most recent price target of $185.00 for 2022 was provided by sixteen renowned analysts over the past few months, with an average prediction of $185.00. If this prediction is correct, Johnson & Johnson's stock could rise by 5.41 percent from its current trading price. The potential increase for the stock is $185.00 per share, with a possible range of $167.00 to $215.00. Even if you are not interested in JNJ stock, you should still be aware of its competitors.

$185.00

5.41% Upside

Outperform
Outperform

Johnson & Johnson Price Forecast for 2022 - 2025 - 2030

Johnson & Johnson's Price has seen major growth over the last four years, jumping from $128.63 to $172.68 – an increase of 34.25%. In the next year, analysts predict that Price will reach an unimpressive $180.78 – an increase of 4.69%. For the next nine years, the forecast is for Price to grow by 32.65%

2022 Price Forecast
$180.78
2023 Price Forecast
$192.41
2024 Price Forecast
$201.22
2025 Price Forecast
$212.85
2026 Price Forecast
$209.68
2027 Price Forecast
$209.33
2028 Price Forecast
$215.32
2029 Price Forecast
$219.19
2030 Price Forecast
$229.06
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
ABBV Stock Forecast AbbVie Outperform 5
$152.43 $152.52 10.21% 19
ABT Stock Forecast Abbott Laboratories Outperform 7
$112.74 $141.24 24.18% 19
AZN Stock Forecast AstraZeneca PLC Outperform 3
£102.44 £136.08 42.07% 13
BMY Stock Forecast Bristol-Myers Squibb Outperform 8
$77.02 $76.69 1.27% 16
AMGN Stock Forecast Amgen Hold 8
$243.96 $246.46 1.45% 13

Johnson & Johnson Revenue Forecast for 2022 - 2025 - 2030

Johnson & Johnson's Revenue has seen major growth over the last four years, jumping from $76450.00 to $93775.00 – an increase of 22.66%. In the next year, analysts predict that Revenue will reach an unimpressive $96295.55 – an increase of 2.69%. For the next nine years, the forecast is for Revenue to grow by 12.28%

2022 Revenue Forecast
$96.30k
2023 Revenue Forecast
$100.28k
2024 Revenue Forecast
$103.17k
2025 Revenue Forecast
$106.86k
2026 Revenue Forecast
$105.05k
2027 Revenue Forecast
$105.72k
2028 Revenue Forecast
$103.67k
2029 Revenue Forecast
$103.65k
2030 Revenue Forecast
$105.29k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BDX Stock Forecast Becton, Dickinson and Outperform 5
$251.10 $270.20 13.5% 3
BAYN Stock Forecast Bayer Outperform 5
63.80€ 67.79€ 19.12% 14
CL Stock Forecast Colgate-Palmolive Hold 4
$75.71 $84.90 8.31% 9

Johnson & Johnson Dividend per Share Forecast for 2022 - 2025 - 2030

Over the last four years, Johnson & Johnson's DPS has increased by 26.2%, going from $3.32 to $4.19. In the next year, analysts are expecting a small increase in EPS, predicting it will reach $4.45 – an increase of 6.21%. The 2030 forecast is for DPS to reach $5.75 or grow by 37.23%.

2022 Dividend Forecast
$4.45
2023 Dividend Forecast
$4.63
2024 Dividend Forecast
$4.85
2025 Dividend Forecast
$5.15
2026 Dividend Forecast
$5.27
2027 Dividend Forecast
$5.34
2028 Dividend Forecast
$5.41
2029 Dividend Forecast
$5.51
2030 Dividend Forecast
$5.75
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BSX Stock Forecast Boston Scientific Outperform 4
$40.23 $49.85 24.29% 23
4519 Stock Forecast Chugai Pharmaceutical Hold 3
¥3.79k ¥0.00 18.73% 0
BAS Stock Forecast BASF Outperform 5
49.86€ 78.27€ 28.36% 16

Johnson & Johnson Free Cash Flow Forecast for 2022 - 2025 - 2030

Johnson & Johnson's Free Cash Flow has increased by 11.14% in the last four years, going from $17777.00 to $19758.00. In the next year, analysts expect Free Cash Flow to reach a reasonable $23174.60 – an increase of 17.29%. For the next nine years, the forecast is for Free Cash Flow to grow by 47.66%.

2022 Free Cash Flow Forecast
$23.17k
2023 Free Cash Flow Forecast
$26.97k
2024 Free Cash Flow Forecast
$28.05k
2025 Free Cash Flow Forecast
$26.74k
2026 Free Cash Flow Forecast
$26.55k
2027 Free Cash Flow Forecast
$26.03k
2028 Free Cash Flow Forecast
$25.74k
2029 Free Cash Flow Forecast
$28.81k
2030 Free Cash Flow Forecast
$29.17k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BNTX Stock Forecast BioNTech Hold 0
$284.21 $0.00 -11.75% 3
ALC Stock Forecast Alcon Outperform 0
CHF79.00 CHF0.00 15.3% 14
BAX Stock Forecast Baxter International Outperform 5
$72.12 $92.47 24.79% 3

Johnson & Johnson Net Income Forecast for 2022 - 2025 - 2030

In the past four years, Johnson & Johnson's Net Income has seen a tremendous growth rate, increasing from $1300.00 to $20878.00 – an increase of 1506%. For next year, the 17.00 analysts predict earnings per share of $27222.61, which would mean an increase of 30.39%. Over the next nine years, the pros' prediction is Net Income of $29270.00, which would mean a 9-year growth forecast of 40.2%.

2022 Net Income Forecast
$27.22k
2023 Net Income Forecast
$28.77k
2024 Net Income Forecast
$29.94k
2025 Net Income Forecast
$31.14k
2026 Net Income Forecast
$30.18k
2027 Net Income Forecast
$29.48k
2028 Net Income Forecast
$28.65k
2029 Net Income Forecast
$28.58k
2030 Net Income Forecast
$29.27k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BIIB Stock Forecast Biogen Outperform 4
$195.71 $287.21 16.24% 24
CERN Stock Forecast Cerner Hold 6
$93.97 $93.31 1.1% 3
BGNE Stock Forecast BeiGene Outperform 0
$305.60 $0.00 7.98% 5

Johnson & Johnson EBITDA Forecast for 2022 - 2025 - 2030

In the past four years, Johnson & Johnson's EBITDA has significantly grown, increasing from $24539.00 to $32637.00 – a growth of 33%. The next year looks mildly promising for Johnson & Johnson, with analysts predicting EBITDA of $34274.43 – an increase of 5.02%. Over the next nine years, experts anticipate that JNJ's EBITDA will grow at a rate of 66.01%.

2022 EBITDA Forecast
$34.27k
2023 EBITDA Forecast
$36.70k
2024 EBITDA Forecast
$38.51k
2025 EBITDA Forecast
$41.20k
2026 EBITDA Forecast
$43.65k
2027 EBITDA Forecast
$46.09k
2028 EBITDA Forecast
$48.77k
2029 EBITDA Forecast
$51.44k
2030 EBITDA Forecast
$54.18k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
CHD Stock Forecast Church & Dwight Hold 5
$90.19 $88.52 10.88% 9
AKZA Stock Forecast Akzo Nobel N.V. Outperform 4
93.92€ 113.10€ 15.52% 13
BIO Stock Forecast Bio-Rad Laboratories Outperform 7
$503.49 $701.33 39.03% 2

Johnson & Johnson EBIT Forecast for 2022 - 2025 - 2030

In the last four years, Johnson & Johnson's EBIT has grown by 33.6%, from $18897.00 to $25247.00. For the next year, analysts are expecting EBIT to reach a reasonable $30914.86 – an increase of 22.45%. Over the next nine years, experts predict that EBIT will grow by 39.26%.

2022 EBIT Forecast
$30.91k
2023 EBIT Forecast
$33.15k
2024 EBIT Forecast
$34.55k
2025 EBIT Forecast
$34.38k
2026 EBIT Forecast
$34.46k
2027 EBIT Forecast
$34.67k
2028 EBIT Forecast
$34.83k
2029 EBIT Forecast
$34.98k
2030 EBIT Forecast
$35.16k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
AFX Stock Forecast Carl Zeiss Meditec Hold 4
118.25€ 165.40€ 43.34% 1
BBWI Stock Forecast Bath & Body Works Buy 6
$42.94 $81.26 90.96% 6
A090430 Stock Forecast Amorepacific Outperform 2
₩150.50k ₩269.69k 32.89% 16

Johnson & Johnson EPS Price Prediction Forecast for 2022 - 2025 - 2030

Johnson & Johnson's EPS has seen major growth over the last four years, jumping from $7.30 to $9.80 – an increase of 34.25%. In the next year, analysts predict that EPS will reach an unimpressive $10.26 – an increase of 4.69%. For the next nine years, the forecast is for EPS to grow by 32.65%

2022 EPS Forecast
$10.26
2023 EPS Forecast
$10.92
2024 EPS Forecast
$11.42
2025 EPS Forecast
$12.08
2026 EPS Forecast
$11.90
2027 EPS Forecast
$11.88
2028 EPS Forecast
$12.22
2029 EPS Forecast
$12.44
2030 EPS Forecast
$13.00
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
CLN Stock Forecast Clariant Hold 2
CHF18.99 CHF19.93 5.32% 7
7747 Stock Forecast Asahi Intecc Outperform 1
¥2.56k ¥0.00 17.23% 0
ALKS Stock Forecast Alkermes Hold 0
$25.19 $0.00 13.14% 8

© Copyright 2022 | Stock Forecast | All Rights Reserved